Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines Chain C
CAT No: ta-012
Synonyms/Alias:Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines Chain C (1-9)
NY-ESO-1 peptide is a synthetic peptide fragment derived from the cancer-testis antigen NY-ESO-1, a protein known for its restricted expression in normal testicular tissue and aberrant expression in various malignancies. As a representative member of the cancer-testis antigen family, NY-ESO-1 is widely recognized for its strong immunogenicity and has become a focal point in tumor immunology research. The peptide form is commonly utilized as a defined epitope for probing immune responses, facilitating the study of antigen-specific T cell recognition, and enabling the development of targeted immunological assays. Its unique sequence and immunological relevance have made it an indispensable reagent in the exploration of tumor-associated antigens and immune monitoring strategies.
Immunological assay development: NY-ESO-1 peptide is extensively employed as a defined antigenic epitope in the development and optimization of immunological assays, such as ELISPOT and intracellular cytokine staining. By serving as a specific stimulus, the peptide enables precise quantification and characterization of NY-ESO-1-specific T cell populations in peripheral blood or tissue samples. This application supports the evaluation of immune responses in preclinical research, vaccine studies, and the assessment of antigen-specific cellular immunity, providing valuable insights into the mechanisms of immune recognition and response to tumor antigens.
T cell epitope mapping: Researchers utilize NY-ESO-1 peptide to delineate the precise epitopes recognized by cytotoxic and helper T lymphocytes. Through in vitro stimulation of peripheral blood mononuclear cells or isolated T cell clones, the peptide facilitates the identification of immunodominant regions within the full-length antigen. This approach is critical for understanding the diversity and specificity of T cell repertoires, guiding the rational design of epitope-based vaccines, and informing the selection of immunogenic sequences for further therapeutic development.
Peptide-MHC complex studies: The defined sequence of NY-ESO-1 peptide allows for its use in generating peptide-major histocompatibility complex (MHC) tetramers and multimers. These molecular tools are essential for the direct detection, enumeration, and phenotypic characterization of antigen-specific T cells by flow cytometry. The ability to create stable peptide-MHC complexes with this peptide has advanced the field of immune monitoring, enabling high-resolution analysis of T cell dynamics in various experimental and translational research contexts.
Adoptive T cell therapy research: In the context of adoptive cell transfer studies, NY-ESO-1 peptide serves as a functional reagent for the ex vivo activation and expansion of T cells engineered to recognize tumor antigens. By stimulating T cells with the peptide, researchers can assess antigen specificity, cytotoxic potential, and cytokine production, thereby optimizing protocols for generating potent effector cells. This application supports ongoing efforts to refine adoptive immunotherapy strategies targeting cancer-testis antigens.
Antigen processing and presentation studies: The peptide is also utilized in investigations of antigen processing pathways and MHC class I or II presentation mechanisms. By introducing the synthetic epitope into antigen-presenting cells, scientists can dissect the molecular requirements for efficient peptide loading, presentation, and subsequent T cell activation. Such studies contribute to a deeper understanding of tumor antigen presentation, immune evasion, and the interplay between tumor cells and the immune system, informing the development of novel immunotherapeutic interventions.
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More